Nighat Mehdi
Pediatric Pulmonology · Oklahoma City, OKNPI 1063480382
Payments from drug & device makers
Across 56 payments — averaging $13,368 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$639K
- Astrazeneca UK Limited$87K
- AbbVie$17K
- Mylan Inc.$4K
- AstraZeneca$2K
- Vivus LLC$670
- plus $6 from 1 others
What the payments were for
- Travel & lodging$1,19969%
- Food & beverage$53531%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 35 | $638,766 |
| Astrazeneca UK Limited | 3 | $86,656 |
| AbbVie | 4 | $17,451 |
| Mylan Inc. | 2 | $3,500 |
| AstraZeneca | 8 | $1,570 |
| Vivus LLC | 3 | $670 |
| Novartis | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$1,425
How this compares
Too few pediatric pulmonology providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Other pediatric pulmonology in Oklahoma City
- Santiago ReyesOklahoma City$309K
- Reeja DanielOklahoma City$145
- Richard de VuystOklahoma City$38
- Lee DroemerTulsa$7K
- Joseph WalterTulsa$7K
- Bucy ThomasBethany$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.